Development of a Rapid and Sensitive AlphaLISA-Based Assay for Lassa Virus Glycoprotein Detection
Pathogens · 2026
DOI: 10.3390/pathogens15030243 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pathogens, 2026. Verfasst von Hao Cai und 11 weiteren Autor:innen. Beteiligte Einrichtung: School of Public Health, Southern Medical University, Guangzhou 510515, China. Hauptthemen laut MEDLINE: Lassa virus, Lassa Fever, Antigens, Viral, Glycoproteins. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Research and Development Program of China.
Abstract (Originalsprache)
Lassa virus (LASV), a member of the Arenaviridae family, is the causative agent of Lassa fever (LF), an acute zoonotic hemorrhagic disease transmitted by rodents, characterized by high infectivity and mortality rates. Due to the nonspecific nature of early clinical symptoms, the development of rapid, sensitive, and specific diagnostic methods is critical for effective epidemic control. In this study, the Lassa virus glycoprotein complex (LASV-G) was selected as the target antigen. High-affinity rabbit monoclonal antibodies were generated using a single B-cell cloning approach, and an AlphaLISA (Amplified Luminescent Proximity Homogeneous Assay)-based homogeneous, no-wash detection system was established. Sixteen LASV-G-specific monoclonal antibodies were isolated through flow cytometric sorting, and the optimal antibody pair (56–24) was identified by AlphaLISA pairing and performance screening. The established AlphaLISA system exhibited a limit of detection (LOD) of 0.025 ng/mL, representing approximately a 30-fold increase in sensitivity compared with conventional Enzyme Linked Immunosorbent Assay (ELISA), while reducing the total assay time to less than 30 min. The coefficient of variation (CV) was below 8%, and no cross-reactivity was observed with Ebola, dengue, yellow fever, Zika, or influenza virus antigens. These findings demonstrate that the developed AlphaLISA assay possesses high sensitivity, rapid detection, and good tolerance to matrix effects, significantly improving the efficiency of early LASV antigen detection. This work provides a potential platform for the rapid on-site screening and epidemiological surveillance of highly pathogenic viruses.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Public Health, Southern Medical University, Guangzhou 510515, China.
- State Key Laboratory of Pathogen and Biosecurity, Academy of Military Medical Sciences, Beijing 100071, China.
ORCID-Profile: Hao Cai, Wenhua Huang, Shaolong Chen, Peng Liu, Zhongpeng Zhao
Förderung
- National Key Research and Development Program of China
Zitieren
APA
Cai, H., Lv, Q., Huang, W., Chen, S., Liu, P., Jiang, H., Li, Q., Kong, D., Ren, Y., Zhao, Z., Wan, C., & Jiang, Y. (2026). Development of a Rapid and Sensitive AlphaLISA-Based Assay for Lassa Virus Glycoprotein Detection. Pathogens. https://doi.org/10.3390/pathogens15030243
Vancouver
Cai H, Lv Q, Huang W, Chen S, Liu P, Jiang H, et al. Development of a Rapid and Sensitive AlphaLISA-Based Assay for Lassa Virus Glycoprotein Detection. Pathogens. 2026. doi:10.3390/pathogens15030243
BibTeX
@article{Cai2026,
author = {Cai, Hao and Lv, Qingyu and Huang, Wenhua and Chen, Shaolong and Liu, Peng and Jiang, Hua and Li, Qian and Kong, Decong and Ren, Yuhao and Zhao, Zhongpeng and Wan, Chengsong and Jiang, Yongqiang},
title = {Development of a Rapid and Sensitive AlphaLISA-Based Assay for Lassa Virus Glycoprotein Detection},
journal = {Pathogens},
year = {2026},
doi = {10.3390/pathogens15030243}
}
EUVIMED